Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 1992; Volume 42,Issue 2
  • You have access
    Novel amiloride analog allosterically modulates the alpha 2-adrenergic receptor but does not inhibit Na+/H+ exchange.
    A L Wilson, S W Womble, C Prakash, E J Cragoe, I A Blair and L E Limbird
    Molecular Pharmacology August 1992, 42 (2) 175-179;
  • You have access
    Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.
    J M Zgombick, L E Schechter, M Macchi, P R Hartig, T A Branchek and R L Weinshank
    Molecular Pharmacology August 1992, 42 (2) 180-185;
  • You have access
    Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity.
    M D Hollenberg, S G Yang, A A Laniyonu, G J Moore and M Saifeddine
    Molecular Pharmacology August 1992, 42 (2) 186-191;
  • You have access
    Metabotropic glutamate receptors potentiate ionotropic glutamate responses in the rat dorsal horn.
    D Bleakman, K I Rusin, P S Chard, S R Glaum and R J Miller
    Molecular Pharmacology August 1992, 42 (2) 192-196;
  • You have access
    Immortalized hypothalamic GT1-7 neurons express functional gamma-aminobutyric acid type A receptors.
    T G Hales, H Kim, B Longoni, R W Olsen and A J Tobin
    Molecular Pharmacology August 1992, 42 (2) 197-202;
  • You have access
    Biochemical characterization of kainate receptors from goldfish brain.
    C J Ziegra, J M Willard and R E Oswald
    Molecular Pharmacology August 1992, 42 (2) 203-209;
  • You have access
    N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells.
    D M Chuang, X M Gao and S M Paul
    Molecular Pharmacology August 1992, 42 (2) 210-216;
  • You have access
    Association of solubilized angiotensin II receptors with phospholipase C-alpha in murine neuroblastoma NIE-115 cells.
    S J Mah, A M Ades, R Mir, I R Siemens, J R Williamson and S J Fluharty
    Molecular Pharmacology August 1992, 42 (2) 217-226;
  • You have access
    Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue.
    R Seifert, A Höer, S Offermanns, A Buschauer and W Schunack
    Molecular Pharmacology August 1992, 42 (2) 227-234;
  • You have access
    Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
    R Seifert, A Höer, I Schwaner and A Buschauer
    Molecular Pharmacology August 1992, 42 (2) 235-241;
  • You have access
    A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2'-deoxyuridine in mammalian and bacterial cells.
    K W Barbour, D K Hoganson, S H Berger and F G Berger
    Molecular Pharmacology August 1992, 42 (2) 242-248;
  • You have access
    Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene.
    C J Omiecinski, R Ramsden, A Rampersaud and F G Walz
    Molecular Pharmacology August 1992, 42 (2) 249-256;
  • You have access
    Sequence analysis, in vitro translation, and expression of the cDNA for rat liver minoxidil sulfotransferase.
    S J Hirshey, T P Dooley, I M Reardon, R L Heinrikson and C N Falany
    Molecular Pharmacology August 1992, 42 (2) 257-264;
  • You have access
    Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
    K J Martell, G N Levy and W W Weber
    Molecular Pharmacology August 1992, 42 (2) 265-272;
  • You have access
    Transcriptional regulation of rat microsomal epoxide hydrolase gene by imidazole antimycotic agents.
    S G Kim
    Molecular Pharmacology August 1992, 42 (2) 273-279;
  • You have access
    Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug.
    M Bourdi, J C Gautier, J Mircheva, D Larrey, A Guillouzo, C Andre, C Belloc and P H Beaune
    Molecular Pharmacology August 1992, 42 (2) 280-285;
  • You have access
    Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
    R B Perich, B Jackson, F Rogerson, F A Mendelsohn, D Paxton and C I Johnston
    Molecular Pharmacology August 1992, 42 (2) 286-293;
  • You have access
    Characterization of functional interactions of imidazoquinoxaline derivatives with benzodiazepine-gamma-aminobutyric acidA receptors.
    J D Petke, H K Im, W B Im, D P Blakeman, J F Pregenzer, E J Jacobsen, B J Hamilton and D B Carter
    Molecular Pharmacology August 1992, 42 (2) 294-301;
  • You have access
    Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
    L Ghoda, H S Basu, C W Porter, L J Marton and P Coffino
    Molecular Pharmacology August 1992, 42 (2) 302-306;
  • You have access
    Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II.
    S M Kimmett, R A Whitney and G S Marks
    Molecular Pharmacology August 1992, 42 (2) 307-310;
  • You have access
    Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
    J Hu, S Z Wang, C Forray and E E el-Fakahany
    Molecular Pharmacology August 1992, 42 (2) 311-321;
  • You have access
    Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
    O Manzoni, L Prezeau, F A Rassendren, F Sladeczek, K Curry and J Bockaert
    Molecular Pharmacology August 1992, 42 (2) 322-327;
  • You have access
    Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    S Leonhardt, E Gorospe, B J Hoffman and M Teitler
    Molecular Pharmacology August 1992, 42 (2) 328-335;
  • You have access
    Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.
    P Nambi, H L Wu, M Pullen, N Aiyar, H Bryan and J Elliott
    Molecular Pharmacology August 1992, 42 (2) 336-339;
  • You have access
    Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
    S K Fisher, E L McEwen, S C Lovell and R E Landon
    Molecular Pharmacology August 1992, 42 (2) 340-346;
  • You have access
    Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1, 2, 3, 20, or 21.
    P Robberecht, P Gourlet, P De Neef, M C Woussen-Colle, M C Vandermeers-Piret, A Vandermeers and J Christophe
    Molecular Pharmacology August 1992, 42 (2) 347-355;
  • You have access
    Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors.
    Y Xie, G S Jones and R H Loring
    Molecular Pharmacology August 1992, 42 (2) 356-363;
  • You have access
    Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines.
    J J Enyeart, B A Biagi and B Mlinar
    Molecular Pharmacology August 1992, 42 (2) 364-372;
  • You have access
    Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
    J Giraldo, M Martín, M Campillo and L Pardo
    Molecular Pharmacology August 1992, 42 (2) 373-381;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 42, Issue 2
1 Aug 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics